Activated protein C for the treatment of severe sepsis

This publication has 30 references indexed in Scilit:

• Advances in pathogenesis and management of sepsis
  Current Opinion in Infectious Diseases, 2007
• Decrease in circulating dendritic cells predicts fatal outcome in septic shock
  Intensive Care Medicine, 2006
• Accelerated Lymphocyte Death in Sepsis Occurs by both the Death Receptor and Mitochondrial Pathways
  The Journal of Immunology, 2005
• The Epidemiology of Sepsis in the United States from 1979 through 2000
  New England Journal of Medicine, 2003
• Early Circulating Lymphocyte Apoptosis in Human Septic Shock Is Associated with Poor Outcome
  Shock, 2002
• Risks and Benefits of Activated Protein C Treatment for Severe Sepsis
  New England Journal of Medicine, 2002
• SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY
  Shock, 2001
• Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
  Critical Care Medicine, 2001
• Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
  New England Journal of Medicine, 2001
• Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life
  Critical Care Medicine, 2000